Exploring J. To explore a different substance…

Names:
BDB
J
Benzodioxolylbutanamine
α-Ethyl-3,4-methylenedioxyphenethylamine
2-Amino-1-(3,4-methylenedioxyphenyl)butane
1-(1,3-Benzodioxol-5-yl)-2-butanamine
IUPAC names:
1-(2H-1,3-Benzodioxol-5-yl)butan-2-amine
1-(1,3-Benzodioxol-5-yl)butan-2-amine
94 · C11H15NO2 · 193.242
InChI=1S/C11H15NO2/c1-2-9(12)5-8-3-4-10-11(6-8)14-7-13-10/h3-4,6,9H,2,5,7,12H2,1H3
VHMRXGAIDDCGDU-UHFFFAOYSA-N This stereoisomer Any stereoisomer

Maurer, HH; Kraemer, T; Springer, D; Staack, RF. Chemistry, pharmacology, toxicology, and hepatic metabolism of designer drugs of the amphetamine (Ecstasy), piperazine, and pyrrolidinophenone types. A synopsis. Ther. Drug Monit., 1 Apr 2004, 26 (2), 127–131. 121 kB.

Trachsel, D. Fluorine in psychedelic phenethylamines. Drug Test. Analysis, 1 Jul 2012, 4 (7-8), 577-590. 1.0 MB. https://doi.org/10.1002/dta.413

Johnson, MP; Hoffman, AJ; Nichols, DE. Effects of the enantiomers of MDA, MDMA and related analogues on [3H]serotonin and [3H]dopamine release from superfused rat brain slices. Eur. J. Pharmacol., 16 Dec 1986, 132 (2–3), 269–276. 559 kB. https://doi.org/10.1016/0014-2999(86)90615-1

Nichols, DE; Hoffman, AJ; Oberlender, RA; Jacob, P; Shulgin, AT. Derivatives of 1-(1,3-benzodioxol-5-yl)-2-butanamine: Representatives of a novel therapeutic class. J. Med. Chem., 1 Jan 1986, 29 (10), 2009–2015. 1.0 MB. https://doi.org/10.1021/jm00160a035

Guy, M; Freeman, S; Alder, JF; Brandt, SD. The Henry reaction: spectroscopic studies of nitrile and hydroxylamine by-products formed during synthesis of psychoactive phenylalkylamines. Cent. Eur. J. Chem., 1 Dec 2008, 6 (4), 526–534. 982 kB. https://doi.org/10.2478/s11532-008-0054-z

Nakanishi, K; Miki, A; Zaitsu, K; Kamata, H; Shima, N; Kamata, T; Katagi, M; Tatsuno, M; Tsuchihashi, H; Suzuki, K. Cross-reactivities of various phenethylamine-type designer drugs to immunoassays for amphetamines, with special attention to the evaluation of the one-step urine drug test Instant-View™, and the Emit® assays for use in drug enforcement. Forensic Sci. Int., 10 Apr 2012, 217 (1–3), 174–181. 397 kB. https://doi.org/10.1016/j.forsciint.2011.11.003

Hardman, HF; Haavik, CO; Seevers, MH. Relationship of the structure of mescaline and seven analogs to toxicity and behavior in five species of laboratory animals. Toxicol. Appl. Pharmacol., 1 Jun 1973, 25 (2), 299–309. 751 kB. https://doi.org/10.1016/S0041-008X(73)80016-X

Clark, CR. Synthesis and analytical profiles for regioisomeric and isobaric amines related to MDMA, MDEA and MBDB: Differentiation of drug and non-drug substances of mass spectral equivalence, US DOJ, 1 Oct 2011. 3.9 MB. #1.1-5

Aalberg, L; DeRuiter, J; Noggle, FT; Sippola, E; Clark, CR. Chromatographic and mass spectral methods of identification for the side-chain and ring regioisomers of methylenedioxymethamphetamine. J. Chromatogr. Sci., 1 Aug 2000, 38 (8), 329–336. 861 kB. https://doi.org/10.1093/chromsci/38.8.329 #5

King, LA. New phenethylamines in Europe. Drug Test. Analysis, 1 Jul 2014, 6 (7-8), 808-818. 472 kB. https://doi.org/10.1002/dta.1570

Shulgin, AT. Basic Pharmacology and Effects. In Hallucinogens. A Forensic Drug Handbook; Laing, R; Siegel, JA, Eds., Academic Press, London, 2003; pp 67–137. 6.3 MB.

Nagai, F; Nonaka, R; Kamimura, KSH. The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain. Eur. J. Pharmacol., 22 Mar 2007, 559 (2), 132–137. 399 kB. https://doi.org/10.1016/j.ejphar.2006.11.075 #BDB

Takahashi, M; Nagashima, M; Suzuki, J; Seto, T; Yasuda, I; Yoshida, T. Creation and application of psychoactive designer drugs data library using liquid chromatography with photodiode array spectrophotometry detector and gas chromatography–mass spectrometry. Talanta, 15 Feb 2009, 77 (4), 1245–1272. 1.2 MB. https://doi.org/10.1016/j.talanta.2008.07.062 #BDB

Seto, T; Takahashi, M; Nagashima, M; Suzuki, J; Yasuda, I. The identifications and the aspects of the commercially available uncontrolled drugs purchased between Apr. 2003 and Mar. 2004. Ann. Rep. Tokyo Metr. Inst. P. H., 1 Jan 2005, 56 75–80. 1.2 MB. #BDB MS,NMR,UV

MDMA
MDPH
M-ALPHA
7-Me-MDA · EIDA
N,N-Me-MDPEA
4-MeOMC · Methedrone
2-Me-MDA · 2-Methyl-MDA
5-Me-MDA · 5-Methyl-MDA
6-Me-MDA · 6-Methyl-MDA
4-Ethoxycathinone
α-Me-N-Et-MDBA
α,N,N-TMMDBA
α,α,N-TMMDBA
homo-MDA
2-MeOMC
3-MeOMC
AcO-MePEA
N,N-Me-2,3-MDPEA
N-Et-2,3-MDPEA
2,3-MDMA
2,3-MDPH
2,3-BDB
3,4-DMCPA
N-Et-MDPEA
β,N-Me-MDPEA
EDA
2C-G-1
S-MDMA
R-MDMA
N-Ethyl-N-methylpiperonylamine
2,5-DMAI
Uberine
2520
2521
2522
1094
1007
10552
10548
10474
740
3C-BMH
10081
10076
Tolibut
iso-MDMA
Hydroxytolyl-mephedrone
4-Carboxymethamphetamine
19 September 2018 · Creative Commons BY-NC-SA ·